The potential implication of differential HOX expression in CBF AML subtypes may cooperate with the leukemogenic potential of the two fusion events (CBFB-MYH11 and RUNX1-RUNX1T1)[49]. Here, RUNX1 is linked to acute myeloid leukemia.